Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Dapagliflozin is approved by both the FDA and the EMA for the treatment of Type 2 Diabetes (T2D). In the European Union, dapagliflozin, which is taken orally once a day, is approved for use as a standalone treatment for patients who cannot tolerate metformin. It is also approved as an additional therapy to be used in combination with other glucose-lowering medications, including insulin, for managing Type 2 Diabetes (T2D) when diet and exercise alone are insufficient to achieve adequate glycemic control.
Filippatos et al. 2015 Ther Adv Endocrinol Metab 6(1)…